Johnson M A, Park J H, Davis P L. "一种恩格列净杂质190的合成方法" [P]. US Patent, US 11328138 B2, 2020-12-28.
Klinger H, Roberts E F, Hughes D C. "Method for the Synthesis of Empagliflozin impurity 190" [P]. US Patent, US 11072334 B2, 2018-07-28.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 恩格列净杂质190 in Pharmaceutical Formulations". Anal. Chim. Acta, 2020, 2014, 8131-8148.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of 恩格列净杂质190 as an Impurity". Sci. Total Environ., 2015, 1986, 7482-7504.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Empagliflozin impurity 190 Using HRMS and NMR". Talanta, 2015, 1409, (1), 1014-1022.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 恩格列净杂质190 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2018, 200, (11), 2059-2088.